ClinicalTrials.Veeva

Menu

The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise (KETONE)

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Enrolling

Conditions

Exercise Metabolism

Treatments

Dietary Supplement: CHO+PLACEBO
Dietary Supplement: CHO+KETONE

Study type

Interventional

Funder types

Other

Identifiers

NCT06746805
METC 23-001

Details and patient eligibility

About

The purpose of this study is to examine the effect of exogenous ketone body supplementation on carbohydrate metabolism during exercise. In a randomized, crossover, and double-blind study, 20 endurance trained adult males and females aged 18-50 years, will ingest carbohydrates with either a ketone monoester supplement before and throughout a 3-hour exercise session or carbohydrates with a flavour-matched ketone-free placebo. The main aim of this study is to compare the exogenous carbohydrate oxidation rates during exercise between the ketone monoester and placebo conditions.

Enrollment

27 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-50 years of age
  • Trained cyclist/triathlete (VO2peak > 55 ml/kg/min for males and >48 ml/mg/min for females)
  • Healthy as per medical history and investigator's/physician's judgement
  • Having given written informed consent

Exclusion criteria

  • Use of medication that could impact study outcomes and/or interfere with the expected mechanism of action of ketone supplements (e.g. Chronic use of gastric acid suppressing medication, statins, corticosteroids)
  • Smoking
  • Diagnosed acute or chronic medical conditions that, in the opinion of the investigator, could impact study outcomes (e.g. Diabetes mellitus)
  • Diagnosed musculoskeletal disorders
  • Adhering to a carbohydrate restrictive diet
  • Participation in another study at the same time
  • Blood donation in the 2 months before the first experimental trial
  • Plasma donation in the 2 weeks before the first experimental trial
  • Males: VO2peak <55 ml/min/kg body mass
  • Females: VO2peak <48 ml/min/kg body mass
  • Females: pregnancy

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

27 participants in 2 patient groups, including a placebo group

CHO+KETONE
Experimental group
Description:
Interventional drink with glucose + ketone monoester
Treatment:
Dietary Supplement: CHO+KETONE
CHO+PLACEBO
Placebo Comparator group
Description:
Placebo drink with glucose + placebo
Treatment:
Dietary Supplement: CHO+PLACEBO

Trial contacts and locations

1

Loading...

Central trial contact

Luc van Loon, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems